Press releases
- Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
- Aethlon Medical Announces Pricing of $4.7 Million Public Offering
- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
Key statistics
On Friday, Aethlon Medical Inc (EJU0:FRA) closed at 0.51, 55.49% above the 52 week low of 0.328 set on May 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.484 |
---|---|
High | 0.51 |
Low | 0.484 |
Bid | 0.515 |
Offer | 0.56 |
Previous close | 0.540 |
Average volume | 8.25k |
---|---|
Shares outstanding | 5.05m |
Free float | 4.88m |
P/E (TTM) | -- |
Market cap | 2.07m USD |
EPS (TTM) | -5.03 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 08:06 BST.
More ▼